ANIK
Anika Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ANIK fundamentals
Anika Therapeutics (ANIK) released its earnings on Nov 5, 2025: revenue was 27.80M (YoY -28.35%), met estimates; EPS was 0.04 (YoY +116.00%), beat estimates.
Revenue / YoY
27.80M
-28.35%
EPS / YoY
0.04
+116.00%
Report date
Nov 5, 2025
ANIK Earnings Call Summary for Q3,2025
- Commercial Channel Dominance: 22% YoY growth in Commercial Channel offsets OEM decline, driven by Integrity's 25% YoY procedure growth and international expansion.
- Product Pipeline Progress: Hyalofast PMA submission completed; Cingal bioequivalence study initiation on track for late 2025. Over 1 million Cingal injections globally.
- Financial Discipline: 12% YoY SG&A reduction and $6.9M operating cash flow highlight cost control. $15M share buyback announced.
- Growth Catalysts: New Integrity SKUs launching in Q4; Hyalofast FDA engagement expected; Cingal U.S. launch timeline hinges on bioequivalence study completion.
EPS
Revenue
Revenue & Expenses
ANIK has released its 2025 Q3 earnings report, with revenue of 27.82M, reflecting a YoY change of -5.89%, and net profit of -2.33M, showing a YoY change of 92.22%. The Sankey diagram below clearly presents ANIK's revenue sources and cost distribution.
Key Indicators
Anika Therapeutics (ANIK) key financial stats and ratios, covering profitability, financial health, and leverage.
Anika Therapeutics (ANIK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Anika Therapeutics (ANIK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Anika Therapeutics (ANIK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Anika Therapeutics (ANIK) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Anika Therapeutics (ANIK) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Anika Therapeutics do and what are its main business segments?What were the key takeaways from Anika Therapeutics’s earnings call?What is Anika Therapeutics's gross profit margin?What is Anika Therapeutics's latest dividend and current dividend yield?What factors drove the changes in Anika Therapeutics's revenue and profit?What guidance did Anika Therapeutics's management provide for the next earnings period?What were the key takeaways from Anika Therapeutics's earnings call?What is the market's earnings forecast for Anika Therapeutics next quarter?
